These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24052132)

  • 21. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology.
    von Schweinitz D; Byrd DJ; Hecker H; Weinel P; Bode U; Bürger D; Erttmann R; Harms D; Mildenberger H
    Eur J Cancer; 1997 Jul; 33(8):1243-9. PubMed ID: 9301450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
    Zsíros J; Maibach R; Shafford E; Brugieres L; Brock P; Czauderna P; Roebuck D; Childs M; Zimmermann A; Laithier V; Otte JB; de Camargo B; MacKinlay G; Scopinaro M; Aronson D; Plaschkes J; Perilongo G
    J Clin Oncol; 2010 May; 28(15):2584-90. PubMed ID: 20406943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved long-term survival with preoperative chemotherapy for hepatoblastoma.
    Ehrlich PF; Greenberg ML; Filler RM
    J Pediatr Surg; 1997 Jul; 32(7):999-1002; discussion 1002-3. PubMed ID: 9247221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee.
    Thompson PA; Malogolowkin MH; Furman WL; Piao J; Krailo MD; Chung N; Brock L; Towbin AJ; McCarville EB; Finegold MJ; Ranganathan S; Dunn SP; Langham MR; McGahren ED; Tiao GM; Weldon CB; O'Neill AF; Rodriguez-Galindo C; Meyers RL; Katzenstein HM
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30365. PubMed ID: 37073741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addition of Vincristine and Irinotecan to Standard Therapy in a Patient With Refractory High-risk Hepatoblastoma Achieving Long-term Relapse-free Survival.
    Powers JM; Pacheco MM; Wickiser JE
    J Pediatr Hematol Oncol; 2019 Apr; 41(3):e171-e173. PubMed ID: 29668545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The treatment of hepatoblastoma: Its evolution and the current status as per the SIOPEL trials.
    Aronson DC; Czauderna P; Maibach R; Perilongo G; Morland B
    J Indian Assoc Pediatr Surg; 2014 Oct; 19(4):201-7. PubMed ID: 25336801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT.
    Hishiki T; Matsunaga T; Sasaki F; Yano M; Ida K; Horie H; Kondo S; Watanabe K; Oue T; Tajiri T; Kamimatsuse A; Ohnuma N; Hiyama E
    Pediatr Surg Int; 2011 Jan; 27(1):1-8. PubMed ID: 20922397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatoblastoma: an oncological review.
    Roebuck DJ; Perilongo G
    Pediatr Radiol; 2006 Mar; 36(3):183-6. PubMed ID: 16404556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment outcomes and prognostic factors in children with hepatoblastoma using a risk-stratified approach.
    Srinivasan S; Prasad M; Parambil BC; Shrimal A; Gollamudi VRM; Subramani V; Ramadwar M; Khanna N; Baheti AD; Gala K; Patil V; Laskar S; Qureshi S; Chinnaswamy G
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30302. PubMed ID: 37046413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrolamellar hepatocellular carcinoma in children and adolescents.
    Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Qu W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
    Cancer; 2003 Apr; 97(8):2006-12. PubMed ID: 12673731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.
    Brock PR; Maibach R; Childs M; Rajput K; Roebuck D; Sullivan MJ; Laithier V; Ronghe M; Dall'Igna P; Hiyama E; Brichard B; Skeen J; Mateos ME; Capra M; Rangaswami AA; Ansari M; Rechnitzer C; Veal GJ; Covezzoli A; Brugières L; Perilongo G; Czauderna P; Morland B; Neuwelt EA
    N Engl J Med; 2018 Jun; 378(25):2376-2385. PubMed ID: 29924955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
    Meyers RL; Maibach R; Hiyama E; Häberle B; Krailo M; Rangaswami A; Aronson DC; Malogolowkin MH; Perilongo G; von Schweinitz D; Ansari M; Lopez-Terrada D; Tanaka Y; Alaggio R; Leuschner I; Hishiki T; Schmid I; Watanabe K; Yoshimura K; Feng Y; Rinaldi E; Saraceno D; Derosa M; Czauderna P
    Lancet Oncol; 2017 Jan; 18(1):122-131. PubMed ID: 27884679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival and long-term outcomes in children with hepatoblastoma treated with continuous infusion of cisplatin and doxorubicin.
    Sivaprakasam P; Gupta AA; Greenberg ML; Capra M; Nathan PC
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):e226-30. PubMed ID: 21792028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Dose Chemotherapy with Autologous Stem Cell Transplantation in Hepatoblastoma does not Improve Outcome. Results of the GPOH Study HB99.
    Häberle B; Maxwell R; Schweinitz DV; Schmid I
    Klin Padiatr; 2019 Nov; 231(6):283-290. PubMed ID: 31645068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapeutic approaches for newly diagnosed hepatoblastoma: past, present, and future strategies.
    Trobaugh-Lotrario AD; Katzenstein HM
    Pediatr Blood Cancer; 2012 Nov; 59(5):809-12. PubMed ID: 22648979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A trend of improved survival of childhood hepatoblastoma treated with cisplatin and doxorubicin in Taiwanese children.
    Chiu SN; Ni YH; Lu MY; Lin DT; Lin KH; Lai HS; Chang MH
    Pediatr Surg Int; 2003 Oct; 19(8):593-7. PubMed ID: 14556026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-agent cisplatin treatment of children with high-risk hepatoblastoma.
    Zhang YT; Feng LH; Zhong XD; Wang LZ; Chang J
    J Pediatr Hematol Oncol; 2014 May; 36(4):271-5. PubMed ID: 24309602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging analysis of hepatoblastoma resectability across neoadjuvant chemotherapy.
    Murphy AJ; Ayers GD; Hilmes MA; Mukherjee K; Wilson KJ; Allen WM; Fernandez-Pineda I; Shinall MC; Zhao Z; Furman WL; McCarville MB; Davidoff AM; Lovvorn HN
    J Pediatr Surg; 2013 Jun; 48(6):1239-48. PubMed ID: 23845613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94.
    Fuchs J; Bode U; von Schweinitz D; Weinel P; Erttmann R; Harms D; Mildenberger H
    Klin Padiatr; 1999; 211(4):305-9. PubMed ID: 10472567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical resection and chemotherapy improve survival rate for patients with hepatoblastoma.
    Carceller A; Blanchard H; Champagne J; St-Vil D; Bensoussan AL
    J Pediatr Surg; 2001 May; 36(5):755-9. PubMed ID: 11329582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.